History
Tactile Systems Technology was founded in 1995 by Irene Waldridge, a certified manual lymphatic drainage (MLD) therapist dedicated to finding an effective way to treat lymphedema at home. Combining her knowledge of lymphedema with a background in design, Irene spent six years developing and prototyping the Flexitouch system, an innovative, patented medical device based on the principles of MLD therapy. In 2002, Tactile Systems Technology received clearance from the U.S. Food and Drug Administration (FDA) to market the Flexitouch system for the treatment of lymphedema, and later, for healing chronic wounds.
The company has continued to develop strong professional relationships with clinical experts, medical research centers and healthcare organizations who share a commitment to the study and treatment of lymphedema. More than 280 insurance companies and government agencies, including Medicare, now provide reimbursement for the Flexitouch system.
Industry Recognition and Support
- 2007 Corporation of the Year Award – Lymphatic Research Foundation
- 2008 Platinum Supporter – National Lymphedema Network 8th Annual Conference
- 2008 Premier Corporate Sponsor – Lymphology Association of North America
- LifeScience Alley Member
- Accredited by the Accreditation Commission for Health Care, Inc. (ACHC)
Meet Irene Waldrige, founder of Tactile Systems Technology [VIDEO]